Kåre Schultz, Teva CEO

Opi­oids, price-fix­ing and now kick­backs. Pros­e­cu­tors add an­oth­er ‘en­rich­ing’ scheme to the claims against Te­va

Te­va Phar­ma­ceu­ti­cals $TE­VA is in le­gal trou­ble again, this time for al­leged­ly de­fraud­ing Medicare.

On Tues­day, fed­er­al pros­e­cu­tors sued the Is­raeli drug­mak­er, ac­cus­ing them of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA